Ana səhifə

Table of contents study category page clinical trial 2 behavioral/epidemiologic 43 basic science/virology 71


Yüklə 1.25 Mb.
səhifə9/10
tarix26.06.2016
ölçüsü1.25 Mb.
1   2   3   4   5   6   7   8   9   10




tOTAL nUMBER OF BEHAVIORAL STUDIES listed AS OF 12/06/11 = 160





Basic Science

UNIVERSITY OF CENTRAL FLORIDA – 4 Studies

Presenter: Alexander M. Cole, Ph.D.



Basic Science/Virology

Retrocyclins: circular defensins active against HIV-1 (NIH R01 grant AI052017)

Alexander M. Cole, Ph.D. (PI)

Microbiology and Molecular Biology

Topical microbicides to prevent HIV-1 transmission

Basic Science/Virology

Project 2. Development of RC-101 as an intravaginal topical microbicide. (NIH U19 grant AI082623)

Alexander M. Cole, Ph.D. (PD of Project 2); Phalguni Gupta, Ph.D. (PI; PD of Project 3; U. Pitt); other project and core directors

Microbiology and Molecular Biology

Topical microbicides to prevent HIV-1 transmission

Basic Science/Virology

Aminoglycoside microbicides restore natural anti-HIV-1 retrocyclins (NIH R21 grant AI082693)

Alexander M. Cole, Ph.D. (PI)

Microbiology and Molecular Biology

Innate host defense against HIV-1

Basic Science/Virology

Reawakening retrocyclins to prevent mucosal STIs (Gates Grand Challenges Explorations Award)

Alexander M. Cole, Ph.D. (PI)

Microbiology and Molecular Biology

Innate host defense against STIs, including HIV

UNIVERSITY OF MIAMI – 36 Studies

Presenter: Savita Pahwa, M.D.



Basic Science/Virology

Targeted siRNA delivery as an anti-HIV microbicide

Derek Dykxhoorn

Dr. John T. Macdonald Foundation Department of Human Genetics and the Department of Microbiology and Immunology

Microbicide development

Behavioral/Epidemiological

Basic Science/Virology



Longitudinal analysis of a high risk HIV negative cohort

Derek Dykxhoorn (Human Genetics, Microbiology and Immunology, DCFAR), Lisa Metsch (Epidemiology and Public Health, DCFAR), Jose Castro (Medicine, DCFAR), Savita Pahwa (Microbiology and Immunology, DCFAR), Margaret Fischl (Medicine, DCFAR), Rafick Sekaly (VGTI-Florida, DCFAR), Lydie Trautmann (VGTI-FL, DCFAR)

Human Genetics, Microbiology and Immunology, Epidemiology and Public Health, Medicine, VGTI-FL, Developmental Center for AIDS Research (DCFAR)


Genetics and Genomics of HIV infection, Acute HIV infection (AHI)

Basic Science/Virology

Identification of genetic variations associated with viral set point control in long term non-progessors

Derek Dykxhoorn (Human Genetics, Microbiology and Immunology, DCFAR), Hector Bolivar (Medicine, DCFAR), William Scott (Human Genetics, DCFAR)

Human Genetics, Microbiology and Immunology, Medicine, VGTI-FL, Developmental Center for AIDS Research (DCFAR)

Genetics of HIV infection

Basic Science/Virology

Activation of CD40 by HIV and Role in AIDS Dementia

Mario Stevenson (PI)

Medicine

Identify mechanism by which HIV induces neuronal destruction in AIDS dementia

Basic Science/Virology

Role of Monocytotropism in HIV/SIV Pathogenicity

Mario Stevenson (PI) Keith Mansfield (Harvard)

Medicine

Examine the role of myeloid lineage cells in the persistence & pathogenicity of HIV/SIV

Basic Science/Virology

Cellular Co-Factors of HIV-1 Infection

Mario Stevenson (PI)

Medicine

Identify cellular factors that are commandeered by HIV in its replication cycle. The goal is to identify new targets for therapeutic intervention

Basic Science/Virology

Preclinical Development of HIV-1 Vif Antagonists


Mario Stevenson (PI) Tariq Rana (Burnham), Keith Mansfield (Harvard), Brigitte Beer (Bioqual)

Medicine

Undertake preclinical development of a lead molecule that interferes with the action of the HIV Vif protein.

Basic Science/Virology

Molecular characterization of cryptic HIV-1 replication during HAART (Project 1)


Mario Stevenson (PI) Tim Schacker (U. Minnesota)


Medicine

To identify the viral reservoirs that persist in the face of antiretroviral therapy. Our analysis focuses on the role of the gut lymphoid tissue in viral persistence.

Basic Science/Virology

Pharmacokinetics of HIV-1 with the integrase inhibitor Raltegravir

Mario Stevenson, Rafael Campo (PI)

Medicine

To evaluate whether intensification of ART with Raltegravir reduces the extent of aberrant immune activation and improves on-treatment CD4 gains in HIV infection individualS

Basic Science/Virology

The Role of Myeloid Cells in Viral Replication, Persistence and Neuroinvasion


Mario Stevenson (PI)


Medicine

To determine whether macrophage are a source of persistent virus in patients on ART & to develop a strategy to remove infected macrophage reservoirs using agents that promote macrophage apoptosis

Basic Science/Virology

HIV Exposed Uninfected: Adaptive Immunity

Jose Castro, Margaret Fischl, Rafick Sekaly

Microbiology and Immunology, Medicine, VGTI

Pathogenesis, Mucosal Immunity


Basic Science/Virology

UM Developmental Center For AIDS Research Int'l AIDS Malignancy Initiative Program

Enrique Mesri

Microbiology and Immunology

NCI

Basic Science/Virology

DCFAR- SCCC International Collaborations in AIDS- Malignancies

Enrique Mesri, Gail Shor-Posner, Juan Carlos Ramos

Microbiology and Immunology, Medicine, Pediatrics

 AIDS Malignancies Projects in Brazil and Argentina

NIH


Basic Science/Virology

International Maternal Pediatric Adolescents AIDS Clinical Trails Group Immunology Laboratory

Savita Pahwa,

Microbiology and Immunology


NIAID


Basic Science/Virology

Role of IL21 in HIV infection


Savita Pahwa

Microbiology and Immunology

NIAID

Basic Science/Virology

Effect of Raltegravir on immune activation, immune reconstitution and gut microbial translocation in patients with chronic HIV infection

Savita Pahwa

Microbiology and Immunology

Merck

Basic Science/Virology

Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96

Eckhard Podack, Savita Pahwa


Microbiology and Immunology


NIAID

Basic Science/Virology

HIV Exposed Uninfected: Innate Immunology

Lydie Trautmann, Margaret Fischl, Rafick Sekaly

Microbiology and Immunology, Medicine, VGTI

Pathogenesis, Mucosal Immunity

Basic Science/Virology

Targeted therapy for Burkitt Lymphoma in Resource Poor Settings

Barber Glen

Medicine

NCI

Basic Science/Virology

Targeting of EBV Latency in Burkitt's Lymphoma

Juan Carlos Ramos

Medicine

NCI

Basic Science/Virology

Biochemical Mechanisms of Drug Resistance in HIV RT

Walter A. Scott

Biochemistry & Molecular Biology

NIAID

Basic Science/Virology

Mitochondrial determinations metabolic disease in HIV-infected children

Tracie Miller

Pediatric Metabolic/

Pathogenesis Research



NINR

Basic Science/Virology

Ologonucelotide apatmer ligands to reverse T cell anergy HIV-infected patients

Eli Gilboa

Novel therapeutics and pathogenesis


NIAID

Clinical Trial

Basic Science/Virology



Effect of Raltegravir on immune activation, immune reconstitution and gut microbial translocation in patients with chronic HIV infection

Rafael Campo

Savita Pahwa

Mario Stevenson


Novel therapeutics and pathogenesis


Merck

Basic Science/Virology

HIV-1 C clade progression and neuroaids

Mahendra Kumar


Pathogenesis


NINDS


Basic Science/Virology

Gp96-Ig HIV and SIV vaccines;

HPV based HIV vaccines

Podack, E. R; Franchini, G (NCI); Haddad, E (VGTI); Sekaly, R. (VGTI) Pahwa, S; Altman, N

Vaccine Research


R21, R33 funded; PO1, UO1 pending (NIAID)

Basic Science/Virology

Novel adjuvants

Stone, G.

Vaccine Research

R21, K22, R21 pending NIAID

Basic Science/Virology

TL1A and LMP1

Strbo, N; Stone, G.

Vaccine Research


DCFAR/ NIAID Supplements

Basic Science/Virology

Hu-mice for HIV vaccine research

Gonzales, L; Strbo, N; Podack E.R.

Vaccine Research


Predoctoral stipend from HIV training grant (NIMH)

Basic Science/Virology

Host Defense Regulation and Viral Oncogenesis

Glen Barber

AIDS Malignancies

NCI

Basic Science/Virology

Role of RAC and Reactive Oxygen Species in Kaposi’s Sarcoma Viral Oncogenesis

Enrique Mesri

P Goldschmidt



AIDS Malignancies


NCI

Basic Science/Virology

Biology of KSHV/HHV8 G Protein Coupled Receptor

Enrique Mesri

AIDS Malignancies


NCI

Basic Science/Virology

A Prospective, Open-Label, Double-Arm, Crossover, Single-Center Pilot Study to Evaluate the Addition of Raltegravir to Established Suppressive Antiretroviral Therapy while Monitoring Changes in Markers of Immune Activation among HIV-1 Infected Individuals Without Adequate Immune Restoration. (35835)

Rafael Campo


Medicine

Immune reconstitution

Basic Science/Virology

140 - Clinical Evaluation of the Xpert® CT/NG Assay

Jose Castro

New – enrolling soon



Medicine

Efficacy

Basic Science/Virology

73B - Evaluation of the Xpert® CT/NG Assay

Jose Castro

New Enrolling soon



Medicine

Efficacy

Basic Science/Virology

Effect of Raltegravir on immune activation, immune reconstitution and gut microbial translocation in patients with chronic HIV infection






Industry Studies


Immune reconstitution

UNIVERSITY OF SOUTH FLORIDA – 13 Studies

Presenter: John W. Sleasman, M.D.



Basic Science/Virology

R01 AI47723-04A1; NIAID. Impact of HIV-1 Genotype on Therapy Response in Children

John Sleasman, MD (PI), Carina Rodriguez, MD, Soichi Haraguchi, PhD, Patricia Emmanuel, MD (Co-Investigators)

Allergy and Immunology

Impact of HIV resistance in immunologic and viral responses in HIV-1 infected children and adolescents

Basic Science/Virology

Defective immunoglobulin somatic hypermutation results in pneumococcal vaccination hyporesponsiveness in HIV infected children. Center for Florida AIDS Research

Carina Rodriguez, MD (PI), John Sleasman, MD, Li Yin, PhD, Maureen Goodenow, PhD.

Pediatric Infectious Diseases, Allergy and Immunology (USF) and Pathology (UF)

Impact of HIV infection on B cell repertoire and somatic mutation and the role of vaccine response

Basic Science/Virology

Do children with HIV have disregulated amyloid loads in their blood?



Brian Giunta, MD (PI), Carina Rodriguez, MD, Patricia Emmanuel, MD, John Sleasman, MD, Jaime Fernandez, MD, Frank Fernandez, MD

Psychiatry and Pediatric Infectious Diseases

Changing levels of amyloid beta in peripheral blood and HIV viral infection. Basic/translational, immune response

Basic Science/Virology

Substance use and immunity function in HIV+ adolescents by systems biology

Maureen Goodenow, John Sleasman

Pathology, UF Allergy and Immunology, USF

Substance use and immunity function in HIV adolescents

Sponsor: NIDA



Basic Science/Virology

Impact of HIV-1 Genotype on Therapy Response in Children.

Maureen Goodenow, John Sleasman

Pathology, UF Allergy and Immunology, USF

Structure function relationships between HIV-1 protease and p7NC.

Sponsor: NIAID



Basic Science/Virology

Role of HIV-1 Env Diversityin Cellular Tropism

Maureen Goodenow, John Sleasman

Pathology, UF Allergy and Immunology, USF

HIV-1 envelope and CD4 target cells.

Sponsor: NICHD



Basic Science/Virology

Studies of Ocular Complications of AIDS (SOCA)

Peter Pavan (PI)

Ophthalmology

Complications, ocular diseases, AIDS, CMV

Basic Science/Virology

Defective immunoglobulin somatic hypermutation results in pneumococcal vaccination hyporesponsiveness in HIV infected children

Carina Rodriguez (PI)

Pediatrics

basic/translational, immune response

Basic Science/Virology

Changes in the B cell repertoire following vaccination with novel H1N1 inactivated influenza vaccine in immune deficient adolescents and young adults chronically infected with HIV

Carina Rodriguez (PI)

Pediatrics

basic/translational, immune response

Basic Science/Virology

The Role of HIV-TAT in Alzheimer’s Disease

Richard Dembo (PI)

Psychiatry and Neurosciences

Prevention; Drug Use

Basic Science/Virology

Uncovering Co-stimulatory T Cell Help Defects in Common Variable Immunodeficiency

Elena Perez (PI)

Pediatrics




Basic Science/Virology

Green Tea Derived EGCG Opposes AIDS Dementia-Like Neuronal Damage

Jun Tan (PI)

Psychiatry and Neurosciences




Basic Science/Virology

Role of Cannabinoid 2 Receptors in B Lymphocyte Function

Catherin Patterson (PI)

Biochemistry




UNIVERSITY OF FLORIDA

Presenter: Maureen Goodenow, Ph.D. - 14 studies



Basic Science/Virology

Substance use and immunity in HIV+ infected adolescents by systems biology

Maureen Goodenow (PI), Li Yin (Co-PI), Mark Wallet; John W. Sleasman, USF, co PI; Sharon Nichols, University of California, San Diego

Pathology

HIV and adolescents

Basic Science/Virology

Human Immunodeficiency Virus Proteinase

Ben Dunn (PI), Maureen Goodenow (Co-I)

Pathology

Mechanisms of HIV drug resistance to protease inhibitors

Basic Science/Virology

Role of HIV-1 Env Diversity in Cellular Tropism

Maureen Goodenow (PI), Li Yin (Co-PI); John W. Sleasman, co-PI USF

Pathology

Mechanisms of HIV-1 entry into macrophages and genetic determinants in envelope that modulate macrophage infection; deep pyrosequencing of HIV-1 variants in longitudinal study

Basic Science/Virology

Impact of HIV-1 Genotype on Therapy Response in Children

John Sleasman (PI), USF, Maureen Goodenow (Co-PI)

Pathology

Mechanisms of HIV-1 genotype and therapy outcome in children

Basic Science/Virology

Characterization of novel polyreactive anti-HIV antibodies in autoimmunity

Maureen Goodenow (PI), Li Yin (Co-I), Mark Wallet; John W. Sleasman, co-PI USF

Pathology

HIV vaccine; deep pyrosequencing of human immunoglobulin repertoire and novel phage display library from autoimmune individuals to identify broadly neutralizing antibodies against HIV-1

Basic Science/Virology

Molecular mechanisms of skeletal muscle loss in HIV-infected older persons

Marco Pahor (PI), Christiaan Leeuwenburgh, Maureen Goodenow, Todd Manini, Bradley Bender, Madhuri Sankuratri, Kevin Yarasheski, Martin Rhee

Geriatrics and Aging Research; Pathology

Effects of HIV-1 on strength and fatigue in older infected individuals; peripheral blood biomarkers of inflammation and innate immune activation

Basic Science/Virology

Viral evolution in peripheral macrophages and brain during progression to AIDS

Marco Salemi (PI), Maureen Goodenow (Co-I), Rebecca Gray

Pathology

Viral dynamics of neuroAIDS in macaque model

Basic Science/Virology

Alveolar Macrophage Proteomics in HIV-Induced Emphysema

Thomas Clanton (PI)

Exercise and Sports Sciences

Pathogenesis

Basic Science/Virology

Rational design of HIV fusion inhibitors targeting GP 41

Alan R. Katritzky (PI)

Chemistry

Drug Design

Basic Science/Virology

Human Immunodeficiency Virus Proteinase


Ben M. Dunn (PI), Maureen Goodenow (Co-PI)

Biochemistry and Molecular Biology

Drug Therapy

Basic Science/Virology

Combination of CCR5 32 and SIRNAS targeting HIV

Lung-Ji Chang

Molecular Genetics & Micro

Gene Therapy

Basic Science/Virology

Analysis of HIV sequence data

Marco Salemi (PI)

Pathology

Molecular Epidemiology

Basic Science/Virology

Foamy virus vector for Immunodeficiency viruses therapy

Ayalew Mergia (PI)

Pathobiology

Gene Therapy

Basic Science/Virology

Protective CMI mechanisms of a dual subtype FIV Vaccine

Janet K. Yamamoto (PI)

Pathobiology

Vaccine



STATE BUREAU OF LABORATORIES – 5 Studies

Presenter: Berry Bennett, M.P.H.



Basic Science/Virology

(Planned) Implementation of a 4th Generation HIV-1/2 Ag/Ab Screening assay and a Non-Traditional Confirmatory Process

B. Bennett (PI), D. Willis, M. Salfinger, M. Diamante

Retrovirology, Jacksonville & Miami

Laboratory/Patient Care – HIV-1 acute infection detection and the implementation of a new HIV diagnostic algorithm

Basic Science/Virology

Correlation on the Use of a Reactive Signal to Cutoff Threshold Value in a 3rd Generation HIV-1/2 Antibody Immunoassay to Expedite Supplemental Testing and Reduce Screening Costs. Poster, 2010 HIV Diagnostic Conference, March 2010, Orlando

Bennett B (PI), Fordan S, Diamante M, et.al.

Retrovirology, Jacksonville & Miami

Laboratory

Basic Science/Virology

Performance of the Aptima HIV-1 RNA Qualitative Assay with 16- and 32-Member Specimen Pools. Journal of Clinical Microbiology, Vol. 48, No. 9, Sept. 2010, p. 3343-3345

Ethridge S (PI), Bennett, B, Stephens, P, et.al.

Retrovirology, Jacksonville & Albany; CDC and NYDOH LABORATORY



Laboratory

Basic Science/Virology

Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings. PLoS Medicine, Vol. 7, Issue 9, Sept. 2010, e1000342

Hutchinson A (PI), Bennett B, et.al.



Retrovirology, Jacksonville & Albany; CDC and

NYDOH LABORATORY



Laboratory



Basic Science/Virology

Detecting Acute Human Immunodeficiency Virus Infection Using 3 Different Screening Immunoassays and Nucleic Acid Amplification Testing for Human Immunodeficiency Virus RNA, 2006-2008, Archives of Internal Medicine, Vol 170 (#1), Jan. 11, 2010


Patel P (PI), Bennett B, Lalota M, Simmons P, et.al.

Retrovirology, Jacksonville & Albany; Prevention Program; CDC and NY LABORATORY

Laboratory/Prevention
1   2   3   4   5   6   7   8   9   10


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət